Acute lymphoblastic leukemia, 3D illustration showing abundant lymphoblasts in blood

An In-depth Update on the Management of Acute Lymphoblastic Leukemia

Program Overview

This CME/CNE program will provide a comprehensive update of best practices for treating and managing patients with acute lymphoblastic leukemia (ALL). The expert faculty will outline molecular mutations and patient prognosis, including the t-acute lymphoblastic leukemia and the b-acute lymphoblastic leukemia subtypes. Current clinical trial data will be analyzed, particularly recent breakthroughs in the care of adults with ...
View Course
Micrograph of Invasive urothelial carcinoma high grade. Invasive urothelial carcinoma is a type of Transitional cell carcinoma (TCC, also urothelial cell carcinoma or UCC) and is a type of cancer that develops in the urinary system: the kidney, urinary bladder, and accessory organs. It is the most common type of bladder cancer and cancer of the ureter, urethra, and urachus. Invasive urothelial carcinoma originates from tissue lining the inner surface of these hollow organs - transitional epithelium. It can extend from the kidney collecting system to the bladder. H&E Stain

Scientific Updates for Optimal Outcomes in Patients with Bladder Cancer

Program Overview

This CME/CNE activity will review recent advances in patients with Bladder Cancer as presented at the American Society of Clinical Oncology- Genitourinary Cancers (ASCO GU) 2019 Symposium in San Francisco, CA. Dr. Richard Lee will inform on clinical decision making for patients with bladder cancer by reviewing the science and tumor microenvironment. He will also discuss the latest clinical treatment ...
View Course
Micrography showing rat liver cancer histology, micrograph, photo under microscope, HE staining

Scientific Updates for Improved Outcomes in Patients with Hepatocellular Carcinoma

Program Overview

This CME/CNE program will provide learners with an update regarding treatment and management of patients with hepatocellular carcinoma (HCC) through an interactive panel format. The expert faculty will first set the stage for modern day HCC care, reviewing the science, prevalence and current treatment guidelines. Recent clinical trial data of first line, second line and combination therapies will ...
View Course
Micrograh of small cell carcinoma or also know as small cell lung cancer or oat-call carcinoma is a type of highly malignant cancer. PAP Stain

Best Practices for the Management of Non-Small Cell Lung Cancer

Program Overview

This CME/CNE activity will review recent advances in patients with non-small cell lung cancer (NSCLC) incorporating data presented at the European Society For Medical Oncology (ESMO) 2018 Conference in Munich, Germany. The three expert faculty will analyze clinical trial data on the current science and emerging best practices for the treatment of NSCLC. The faculty will also discuss how ...
View Course
3d render of immune system T cells attacking cancer cells (CAR T-cell therapy)

The Increasing Role of Biosimilars in Oncology

Program Overview

This continuing education activity will focus on recent clinical trial data as well as therapeutic advances in the increasing role of biosimilars in oncology. The three expert faculty will review the fundamentals of biosimilars in oncology, including bioequivalence, totality of evidence, and interchangeability. A review of current clinical trial data of biosimilars for the treatment of various oncologic ...
View Course
Microscopic photograph of a professionally prepared slide demonstrating lymph node with metastatic colonic adenocarcinoma. H&E stain.

The Role of Novel Therapeutics for the Treatment of Metastatic Colorectal Cancer

Program Overview

This continuing education activity will focus on recent clinical trial data and scientific advances in the treatment and management of patients with metastatic colorectal cancer as presented at the 2018 Gastrointestinal Cancers Symposium held in San Francisco, California. Three expert faculty will review the science of colorectal cancer, including patient screening guidelines and molecular characterization. Recent clinical trial ...
View Course
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

A Clinical Analysis of Optimal Therapeutics to Improve Outcomes in Patients with Advanced Prostate Cancer

Program Overview

This CE program will analyze optimal therapeutics for the treatment and management of prostate cancer patients, incorporating data presented at the American Society of Clinical Oncology 2018 Genitourinary (GU) Cancers Symposium in San Francisco, California. The three expert faculty, led by Dr. Elisabeth Heath, will review the framework for clinical decision making in prostate cancer. Recent clinical trial ...
View Course
910791 116 x 140

The Role of Oncolytic Viral Therapy in the Management of Patients With Metastatic Melanoma

Program Overview

This CME/CE program will delve into the role of oncolytic viral therapy in the treatment and management of the metastatic melanoma patients, highlighting data presented at the Maui and Hawaii Dermatology 2018 annual meetings. The three expert faculty will review the immunotherapy for melanoma, followed by a discussion of recent safety and efficacy trial data for this emerging ...
View Course
Screen Shot 2019-06-12 at 10.25.46 AM

Updated Therapeutic Strategies to Improve Outcomes in Patients with Breast Cancer

Program Overview

This CME/CNE program will highlight recent advances in the treatment and management of breast cancer, as presented at the 40th Annual San Antonio Breast Cancer Symposium in San Antonio, Texas. Three expert faculty will review the pathophysiology of breast cancer and the rationale for therapeutic choices. An evaluation of recent clinical trial data of current and emerging therapies ...
View Course
Blood smear.  Chronic myelogenous or granulocytic leukemia. Abundant immature myeloid cells. Wright stain.

Novel Therapeutics in the Treatment and Management of Multiple Myeloma at ASH 2017

Program Overview

This CME/CNE program will discuss recent advances in the treatment and management of multiple myeloma (MM) as presented at the American Society of Hematology 59th Annual Meeting & Exposition in Atlanta, Georgia. The expert faculty panel will provide learners with a scientific update regarding kidney toxicity, fractures, and other skeletal related events as they relate to MM patient ...
View Course
Loading...